!"# %&"#'()'* +,'-"&".(*# *# /,),"&'0 1)),))2,#.

!"##$%& ()$*%)* $%#+ #,* -((*((.*%# +/ 0*(*-0),

There is a pressing need to improve the ways in which the output of scientific research is
evaluated by funding agencies, academic institutions, and other parties.

To address this issue, a group of editors and publishers of scholarly journals met during
the Annual Meeting of The American Society for Cell Biology (ASCB) in San Francisco,
CA, on December 16, 2012. The group developed a set of recommendations, referred to
as the San Francisco Declaration on Research Assessment. We invite interested parties
across all scientific disciplines to indicate their support by adding their names to this
Declaration.

The outputs from scientific research are many and varied, including: research articles
reporting new knowledge, data, reagents, and software; intellectual property; and highly
trained young scientists. Funding agencies, institutions that employ scientists, and
scientists themselves, all have a desire, and need, to assess the quality and impact of
scientific outputs. It is thus imperative that scientific output is measured accurately and
evaluated wisely.

The Journal Impact Factor is frequently used as the primary parameter with which to
compare the scientific output of individuals and institutions. The Journal Impact Factor,
as calculated by Thomson Reuters, was originally created as a tool to help librarians
identify journals to purchase, not as a measure of the scientific quality of research in an
article. With that in mind, it is critical to understand that the Journal Impact Factor has a
number of well-documented deficiencies as a tool for research assessment. These
limitations include: A) citation distributions within journals are highly skewed [13]; B) the
properties of the Journal Impact Factor are field-specific: it is a composite of multiple,
highly diverse article types, including primary research papers and reviews [1, 4]; C)
Journal Impact Factors can be manipulated (or gamed) by editorial policy [5]; and D)
data used to calculate the Journal Impact Factors are neither transparent nor openly
available to the public [4, 6, 7].

Below we make a number of recommendations for improving the way in which the
quality of research output is evaluated. Outputs other than research articles will grow in
importance in assessing research effectiveness in the future, but the peer-reviewed
research paper will remain a central research output that informs research assessment.
Our recommendations therefore focus primarily on practices relating to research articles
published in peer-reviewed journals but can and should be extended by recognizing
additional products, such as datasets, as important research outputs. These
recommendations are aimed at funding agencies, academic institutions, journals,
organizations that supply metrics, and individual researchers.

A number of themes run through these recommendations:
! the need to eliminate the use of journal-based metrics, such as Journal Impact
Factors, in funding, appointment, and promotion considerations;
! the need to assess research on its own merits rather than on the basis of the
journal in which the research is published; and
! the need to capitalize on the opportunities provided by online publication (such
as relaxing unnecessary limits on the number of words, figures, and references in
articles, and exploring new indicators of significance and impact).

We recognize that many funding agencies, institutions, publishers, and researchers are
already encouraging improved practices in research assessment. Such steps are
beginning to increase the momentum toward more sophisticated and meaningful
approaches to research evaluation that can now be built upon and adopted by all of the
key constituencies involved.

The signatories of the San Francisco Declaration on Research Assessment support the
adoption of the following practices in research assessment.

General Recommendation
1. Do not use journal-based metrics, such as Journal Impact Factors, as a
surrogate measure of the quality of individual research articles, to assess an
individual scientists contributions, or in hiring, promotion, or funding decisions.

For funding agencies
2. Be explicit about the criteria used in evaluating the scientific productivity of grant
applicants and clearly highlight, especially for early-stage investigators, that the
scientific content of a paper is much more important than publication metrics or
the identity of the journal in which it was published.
3. For the purposes of research assessment, consider the value and impact of all
research outputs (including datasets and software) in addition to research
publications, and consider a broad range of impact measures including
qualitative indicators of research impact, such as influence on policy and
practice.

For institutions
4. Be explicit about the criteria used to reach hiring, tenure, and promotion
decisions, clearly highlighting, especially for early-stage investigators, that the
scientific content of a paper is much more important than publication metrics or
the identity of the journal in which it was published.
5. For the purposes of research assessment, consider the value and impact of all
research outputs (including datasets and software) in addition to research
publications, and consider a broad range of impact measures including
qualitative indicators of research impact, such as influence on policy and
practice.

For publishers
6. Greatly reduce emphasis on the journal impact factor as a promotional tool,
ideally by ceasing to promote the impact factor or by presenting the metric in the
context of a variety of journal-based metrics (e.g., 5-year impact factor,
EigenFactor [8], SCImago [9], h-index, editorial and publication times, etc.) that
provide a richer view of journal performance.
7. Make available a range of article-level metrics to encourage a shift toward
assessment based on the scientific content of an article rather than publication
metrics of the journal in which it was published.
8. Encourage responsible authorship practices and the provision of information
about the specific contributions of each author.
9. Whether a journal is open-access or subscription-based, remove all reuse
limitations on reference lists in research articles and make them available under
the Creative Commons Public Domain Dedication [10].
10. Remove or reduce the constraints on the number of references in research
articles, and, where appropriate, mandate the citation of primary literature in
favor of reviews in order to give credit to the group(s) who first reported a finding.

For organizations that supply metrics
11. Be open and transparent by providing data and methods used to calculate all
metrics.
12. Provide the data under a licence that allows unrestricted reuse, and provide
computational access to data, where possible.
13. Be clear that inappropriate manipulation of metrics will not be tolerated; be
explicit about what constitutes inappropriate manipulation and what measures
will be taken to combat this.
14. Account for the variation in article types (e.g., reviews versus research articles),
and in different subject areas when metrics are used, aggregated, or compared.

For researchers
15. When involved in committees making decisions about funding, hiring, tenure, or
promotion, make assessments based on scientific content rather than publication
metrics.
16. Wherever appropriate, cite primary literature in which observations are first
reported rather than reviews in order to give credit where credit is due.
17. Use a range of article metrics and indicators on personal/supporting statements,
as evidence of the impact of individual published articles and other research
outputs [11].
18. Challenge research assessment practices that rely inappropriately on Journal
Impact Factors and promote and teach best practice that focuses on the value
and influence of specific research outputs.



References

1. Adler, R., Ewing, J., and Taylor, P. (2008) Citation statistics. A report from the
International Mathematical Union.
www.mathunion.org/publications/report/citationstatistics0

2. Seglen, P.O. (1997) Why the impact factor of journals should not be used for
evaluating research. BMJ 314, 498502.

3. Editorial (2005). Not so deep impact. Nature 435, 10031004.

4. Vanclay, J.K. (2012) Impact Factor: Outdated artefact or stepping-stone to journal
certification. Scientometric 92, 211238.

5. The PLoS Medicine Editors (2006). The impact factor game. PLoS Med 3(6): e291
doi:10.1371/journal.pmed.0030291.

6. Rossner, M., Van Epps, H., Hill, E. (2007). Show me the data. J. Cell Biol. 179,
10911092.

7. Rossner M., Van Epps H., and Hill E. (2008). Irreproducible results: A response to
Thomson Scientific. J. Cell Biol. 180, 254255.

8. http://www.eigenfactor.org/

9. http://www.scimagojr.com/

10. http://opencitations.wordpress.com/2013/01/03/open-letter-to-publishers

11. http://altmetrics.org/tools/



1 Luan Adle AlLmeLrlc LL
2 LllzabeLh M. Adler LxecuLlve LdlLor, !"# %&'()*+ &, -#)#(*+ ."/01&+&2/
3 Sharon Ahmad LxecuLlve LdlLor, %&'()*+ &, 3#++ 451#)5#
4 kurL P. AlberLlne LdlLor-ln-Chlef, !"# 6)*7&815*+ 9#5&(:
3 8ruce AlberLs LdlLor-ln-Chlef, 451#)5#
6 !ose M. Amlg rofessor LmerlLus, unlLy of CrysLallography and Mlneralogy, ueparLmenL of Ceology,
unlverslLy of valencla, Spaln
7 arker AnLln LdlLor-ln Chlef, ;#<#+&=8#)7*+ ;/)*8150
8 Slmeon Arsenlyadls 8esearch ulrecLor, Cn8S-lrance
9 ueLlef Axmann rofessor, ueparLmenL of rosLhodonLlcs and Medlcal MaLerlals, Lberhard-karls-
unlverslLy, Cermany
10 1oncl 8allc-Zunlc AssoclaLe rofessor ln Mlneralogy and leader of Lhe CrysLallography & Mlneralogy
Croup, naLural PlsLory Museum, unlverslLy of Copenhagen, uenmark
11 !oel 8ernsLeln rofessor, ueparLmenL of ChemlsLry, new ?ork unlverslLy Abu uhabl, unlLed Arab
LmlraLes
12 SLefano 8erLuzzl LxecuLlve ulrecLor, Amerlcan SocleLy for Cell 8lology
13 1ed 8lanco AcLlng ulrecLor, Wellcome 1rusL
14 !oel 8ockaerL rofessor, unlverslLy of MonLpelller 1, lrance, Member, Academle des Sclences
13 Llena 8oldyreva novoslblrsk SLaLe unlverslLy, lnsLlLuLe of Solld SLaLe ChemlsLry and
MechanochemlsLry, Slberlan 8ranch of 8usslan Academy of Sclences
16 uavld 8oLsLeln loundlng LdlLor-ln-Chlef of >&+#5'+*( ?1&+&2/ &, 7"# 3#++, ulrecLor Lewls-Slgler
lnsLlLuLe for lnLegraLlve Cenomlcs, rlnceLon unlverslLy
17 nouzha 8ouhmalda rofessor, LaboraLolre Sclences ues MaLerlaux, laculLe ues Sclences, Marrakech,
Morocco
18 8oque !. Calvo LxecuLlve ulrecLor, LCS - 1he LlecLrochemlcal SocleLy
19 Mlchael Caplan rofessor and Chalr, uepL. of Cellular and Molecular hyslology, ?ale unlverslLy
20 !ullo L. Cells LdlLor-ln-Chlef, >&+#5'+*( @)5&+&2/
21 MarLln Cernohorsky 8ecLor emerlLus, Slleslan unlverslLy ln Cpava, rofessor emerlLus, Masaryk unlverslLy,
8rno, Czech 8epubllc
22 vlckl Chandler Cordon and 8eLLy Moore loundaLlon
23 uanlel ChoqueL 8esearch ulrecLor, Cn8S, ulrecLor of Lhe lnLerdlsclpllnary lnsLlLuLe for neurosclence,
ulrecLor of Lhe 8ordeaux lmaglng CenLer, Member of Lhe Academy
24 uon Cleveland resldenL, Amerlcan SocleLy for Cell 8lology, ulsLlngulshed rofessor and Chalr, uepL.
of Cellular and Molecular Medlclne, unlv. of Callfornla, San ulego
23 lrancolse Combes CbservaLolre de arls and Academle des Sclences
26 aul CouranL Parold 1. Shaplro rofessor of ubllc ollcy, unlverslLy of Mlchlgan
27 8rendan Crabb resldenL, AssoclaLlon of AusLrallan Medlcal 8esearch lnsLlLuLes, ulrecLor, 1he 8urneL
lnsLlLuLe, Melbourne
28 Ana Marla Cuervo co-LdlLor-ln-Chlef of 621)2 3#++, rofessor, AlberL LlnsLeln College of Medlclne
29 SLephen Curry rofessor and Chalr, ueparLmenL of Llfe Sclences, lmperlal College, London
30 AnLonella ue MaLLels 1eleLhon lnsLlLuLe of CeneLlcs and Medlclne
31 1racey ueellegrln LxecuLlve LdlLor, -ABA!C34 and -DE -#)#0F-#)&8#0F-#)#7150
32 Mlchel uesarmenlen 8esearch ulrecLor, Cn8S-lrance
33 uanny uolev SclenLlflc Councll, L8C, School of Lnglneerlng and CompuLer Sclence, 1he Pebrew
unlverslLy of !erusalem
34 ALhene M. uonald Cavendlsh LaboraLory, Cambrldge, uk
33 uavld urubln LdlLor-ln-Chlef, >&+#5'+*( ?1&+&2/ &, 7"# 3#++G rofessor, unlverslLy of Callfornla,
8erkeley
36 8arbara Lnsoll ulrecLor, naLlonal AluS CenLer
37 Wolfgang LppenschwandLner LxecuLlve CoordlnaLor, lnlLlaLlve for Sclence ln Lurope (lSL)
38 uanlel LsLeve CuanLronlcs group, SLC-CLA Saclay
!"#$ &' ()"*"+,- ."*+/)# 01+2"3"24,-#5
39 avel Lxner SclenLlflc ulrecLor, uoppler lnsLlLuLe for MaLhemaLlcal hyslcs and Applled
MaLhemaLlcs rague, Czech 8epubllc
40 Adam . lagen LxecuLlve ulrecLor, CeneLlcs SocleLy of Amerlca
41 Slr Alan lershL, l8S AssoclaLe LdlLor, .B64
42 Lszl lesus Chalrman of ubllcaLlons CommlLLee, lederaLlon of Luropean 8lochemlcal SocleLles
43 MarLy lrank LxecuLlve ulrecLor, 1he Amerlcan hyslologlcal SocleLy
44 1onl Cabaldn CenLre for Cenomlc 8egulaLlon, 8arcelona, Spaln
43 SanLlago Carcla-Cranda rofessor, hyslcal ChemlsLry, unlverslLy of Cvledo, lmmedlaLe asL-resldenL,
Luropean CrysLallographlc AssoclaLlon
46 !uan Manuel Carcla-8ulz 8esearch rofessor aL Lhe Conse[o Superlor de lnvesLlgaclones ClenLlflcas and
unlverslLy of Cranada
47 lernando Carzon resldenL, LCS - 1he LlecLrochemlcal SocleLy
48 Marlna CeberL Croup Leader AquaLlc Cell 1echnology, lraunhofer lnsLlLuLlon for Marlne
8loLechnology, Luebeck, Cermany
49 !ames CenLlle uean, naLural & Applled Sclences, Pope College, asL resldenL, 8esearch
CorporaLlon for Sclence AdvancemenL, former LdlLor-ln-Chlef, MuLaLlon 8esearch
30 Alexander Cerber Managlng ulrecLor, Cerman 8esearch CenLer for Sclence & lnnovaLlon
CommunlcaLlon (lnnCkCMM)
31 ChrlsLlan Cerlcke Chlef LxecuLlve, 1he Wesley 8esearch lnsLlLuLe, 8rlsbane
32 aul A. Cleeson Pead, ueparLmenL of 8lochemlsLry and Molecular 8lology, 1he unlverslLy of
Melbourne
33 8ruce L. Coode LdlLor, 3/7&0H#+#7&), rofessor, 8lology 8osensLlel 8aslc Medlcal Sclences 8esearch
CenLer, 8randels unlverslLy
34 Sharona Cordon lncomlng LdlLor, %&'()*+ &, -#)#(*+ ."/01&+&2/
33 8oberL M. Craham LxecuLlve ulrecLor, vlcLor Chang Cardlac 8esearch lnsLlLuLe, Sydney, AusLralla
36 eLer Cunnlng resldenL, AusLrallan SocleLy for 8lochemlsLry and Molecular 8lology, LdlLor-ln-Chlef,
8loArchlLecLure, unlverslLy of new SouLh Wales
37 !ohn Curdon lormer Chalrman, Company of 8lologlsLs
38 Llsa Pannan Managlng LdlLor, !(*,,15
39 8lchard W. ParLel LdlLor-ln-Chlef, %&'()*+ &, 7"# 68#(15*) @1+ 3"#81070I 4&51#7/
60 Carl-Penrlk Peldln Ludwlg lnsLlLuLe for Cancer 8esearch, uppsala unlverslLy, Sweden
61 LLlenne Perzog lnLerdlsclpllnary lnsLlLuLe for neuroSclence, 8ordeaux unlverslLy, lrance
62 uennls W. Pess LdlLor, A34 %&'()*+ &, 4&+1: 47*7# 451#)5# J !#5")&+&2/ *): A34 4&+1: 47*7# K#77#(0
63 PerlberL PlrL resldenL, Luropean lanL Sclences CrganlsaLlon (LSC)
64 8rlan Poal LxecuLlve ulrecLor, SocleLy of Lconomlc CeologlsLs
63 !ason PoyL Co-lounder and CLC, eer!
66 lablan PueLLlg AsslsLanL Medlcal ulrecLor, ueparLmenL for rosLhodonLlcs wlLh SecLlon "Medlcal
MaLerlals & 1echnology, " CenLer for uenLlsLry and Cral Medlclne, 1ueblngen
unlverslLy PosplLal
67 SLeve Pumphrles LdlLor-ln-Chlef, 67"#(&05+#(&01L Cfflclal !ournal of Lhe Luropean ALherosclerosls
SocleLy
68 1lm PunL lellow of Lhe 8oyal SocleLy, Chalr, 1he Company of 8lologlsLs.
69 Powy !acobs Chlef LdlLor, A>?@ 9#=&(70
70 8elnhard !ahn ueparLmenL of neuroblology, Ml for 8lophyslcal ChemlsLry, LM8C ubllcaLlons
Advlsory CommlLLee (chalr), LM8L SclenLlflc Advlsory 8oard (vlce chalr), uean,
CLLlngen CraduaLe School for neurosclences, 8lophyslcs, and Molecular 8losclences
71 uavld !ames ulrecLor, ulabeLes and CbeslLy rogram, Carvan lnsLlLuLe of Medlcal 8esearch,
lellow, AusLrallan Academy of Sclence
72 Mark !ohnsLon LdlLor-ln-Chlef of -ABA!C34, rofessor and Chalr, ueparLmenL of 8lochemlsLry and
Molecular CeneLlcs, Lhe unlverslLy of Colorado School of Medlclne
73 8lchard A.L. !ones ex-LdlLor-ln-Chlef, A'(&=#*) ."/015*+ %&'()*+
74 kozo kalbuchl LdlLor-ln-Chlef of 3#++ 47('57'(#0 *): M')571&)0 (Lhe offlclal [ournal of Lhe !apanese
SocleLy for Cell 8lology)
73 Alan krauL LxecuLlve ulrecLor, AssoclaLlon for sychologlcal Sclence
76 karl kuchler Medlcal unlverslLy vlenna, Max l. eruLz LaboraLorles
77 LaurenL Ladepche lnLerdlsclpllnary lnsLlLuLe for neuroSclence, 8ordeaux unlverslLy, lrance
78 lernando !. Lahoz ulrecLor, Chemlcal SynLhesls and Pomogeneous CaLalysls 8esearch lnsLlLuLe, Spanlsh
naLlonal 8esearch CenLer - unlverslLy of Zaragoza, Zaragoza, Spaln
79 ekka Lappalalnen LxecuLlve LdlLor, CyLoskeleLon, 8esearch ulrecLor, lnsLlLuLe of 8loLechnology,
unlverslLy of Pelslnkl
80 8ebecca Laurence ubllsher, MNOOO9#0#*(5" and l1000osLers
81 W. Mark Leader ubllcaLlons ulrecLor, Amerlcan SocleLy for Cell 8lology
82 1homas Lemberger Chlef LdlLor, >&+#5'+*( 4/07#80 ?1&+&2/
83 Marla LepLln ulrecLor, LM8C
84 AnLhony Llnden unlverslLy of Zurlch
83 uanlel Louvard ulrecLor of Lhe 8esearch CenLre lnsLlLuL Curle
86 Mlchael Lynch resldenL, CeneLlcs SocleLy of Amerlca
87 Mlchael Marks Co-edlLor, !(*,,15, rofessor, unlverslLy of ennsylvanla
88 Mark Marsh Co-edlLor, !(*,,15, ulrecLor, Medlcal 8esearch Councll LaboraLory for Molecular Cell
8lology
89 Marc A. MarLl-8enom AssoclaLe LdlLor aL LCS CompuLaLlonal 8lology, naLlonal CenLer for Cenomlc
Analysls and CenLre for Cenomlc 8egulaLlon, 8arcelona, Spaln
90 1homas Marwlck ulrecLor, Menzles 8esearch lnsLlLuLe 1asmanla
91 aul MaLsudalra Pead, ueparLmenL of 8lologlcal Sclences, naLlonal unlverslLy of Slngapore
92 laln MaLLa[ LM8L ulrecLor Ceneral
93 SaLya[lL Mayor ulrecLor, naLlonal CenLre for 8lologlcal Sclence, 8angalore, lndla
94 1om MlsLell LdlLor-ln-Chlef, !"# %&'()*+ &, 3#++ ?1&+&2/
93 1hor Moeller 8esearcher, lnsLlLuL de Cenomlque loncLlonnelle (lCl), Cn8S
96 Lucla Monaco Chlef SclenLlflc Cfflcer, londazlone 1eleLhon, lLaly
97 Lrlc Murphy LdlLor-ln-Chlef, K1=1:0, a !ournal of Lhe Amerlcan Cll ChemlsLs' SocleLy
98 valery nakarlakov resldenL, Luropean Solar hyslcs ulvlslon, hyslcs ueparLmenL, unlverslLy of
Warwlck, uk
99 Susana naroLzky rofessor, CulLural AnLhropology, unlverslLy of 8arcelona, Spaln
100 Pelga nowoLny resldenL, Luropean 8esearch Councll, WW1l vlenna Sclence and 1echnology lund
101 aul nurse resldenL, 1he 8oyal SocleLy
102 Penk CLLens resldenL, AssoclaLlon of Ceographlcal SocleLles ln Lurope LuCLC
103 Mark aLLerson LxecuLlve ulrecLor, #K1,#
104 Lva ebay-eyroula rofessor, !oseph lourler unlverslLy, Crenoble Member of Lhe lrench Academy of
Sclence
103 edro erelra AssoclaLe 8esearcher, l8MC - lnsLlLuLo de 8lologla Molecular e Celular, orLugal
106 8lchard n. erham LdlLor-ln-Chlef, MA?4 %&'()*+
107 Alalne eyraube ulrecLor of 8esearch aL Lhe Cn8S (lrance)
108 Cllvler lronneau rofessor, L!LL - Analyse numerlque, unlverslLe lerre eL Marle Curle (arls vl)
109 PeaLher lwowar Cofounder, lmpacLSLory
110 Cllvler ourqule LdlLor-ln-Chlef, ;#<#+&=8#)7
111 !acques ouyssegur 8esearch ulrecLor aL Cn8S, Member of lrench & Luropea Academy, nlce
112 AlberLo resLlnlnzl LdlLor-ln -Chlef, C7*+1*) %&'()*+ &, A)21)##(1)2 -#&+&2/ *): A)<1(&)8#)7
113 !ason rlem Co-founder, lmpacLSLory
114 Ldward n. ugh, !r. LdlLor, %&'()*+ &, -#)#(*+ ."/01&+&2/
113 8ernd ulverer Chlef LdlLor, !"# A>?@ %&'()*+, Pead of SclenLlflc ubllcaLlons, LM8C
116 Marlanne Culquandon 8esearcher, Cn8S-lrance
117 !ordan 8aff resldenL, 8rlLlsh SocleLy of Cell 8lology, LdlLor-ln-Chlef, ?1&+&2/ @=#), rofessor,
Cancer Cell 8lology, unlverslLy of Cxford.
118 lranclsco x. 8eal Spanlsh naLlonal Cancer 8esearch CenLer and unlverslLaL ompeu labra
119 Alyson 8eed LxecuLlve ulrecLor, LlngulsLlc SocleLy of Amerlca
120 karl 8lssanen Academy rofessor, ueparLmenL of ChemlsLy, unlverslLy of !yvaskyla, llnland
121 hllllp !. 8oblnson Pead, Cell Slgnalllng unlL, Chlldren's Medlcal 8esearch lnsLlLuLe
122 Mlke 8ossner LxecuLlve ulrecLor, 1he 8ockefeller unlverslLy ress
123 uldler 8oux Member of Lhe lrench Academy of Sclences
124 AnLhony !. 8yan ro vlce Chancellor, laculLy of Sclence, 1he unlverslLy of Sheffleld
123 !ean-Louls Salager LdlLor-ln-Chlef, %&'()*+ &, 4'(,*57*)70 *): ;#7#(2#)70
126 noel 8. Salazar resldenL, Luropean AssoclaLlon of Soclal AnLhropologlsLs
127 Mlchele Savlano resldenL of lLallan AssoclaLlon of CrysLallography, ulrecLor of lnsLlLuLe of
CrysLallography-Cn8
128 8andy Schekman LdlLor-ln-Chlef, #K1,#
129 Sandra Schmld Cecll P. Creen ulsLlngulshed Chalr ln Cellular and Molecular 8lology, rofessor and
Chalr, ueparLmenL of Cell 8lology, unlverslLy of 1exas SouLhwesLern Medlcal CenLer
130 1rlna Schroer Co-edlLor, !(*,,15G rofessor, !ohns Popklns unlverslLy
131 ulrlch SchuberL rofessor, lnsLlLuLe of MaLerlal ChemlsLry, vlenna unlverslLy of 1echnology
132 !rg Schulz LdlLor-ln-Chlef, %&'()*+ &, B#'(&5"#8107(/G Chalr and lull rofessor, ueparLmenL of
neurology, 8W1P Aachen unlverslLy, Cermany
133 Andre SenLenac Member of Lhe lrench Academy of Sclences, lormer ulrecLor of a ueparLmenL of
8lology aL Lhe CLA (ALomlc Lnergy Commlsslon)
134 8oberL Shepherd ulrecLor, 8lonlcs lnsLlLuLe, unlverslLy of Melbourne
133 SLuarL Shleber Parvard unlverslLy
136 1om SLevens Co-edlLor, !(*,,15, rofessor, unlverslLy of Cregon
137 !ennlfer L. SLow rofessor and uepuLy ulrecLor, 8esearch, lnsLlLuLe for Molecular 8losclence, 1he
unlverslLy of Cueensland
138 Sona SLrbanova AssoclaLe rofessor, CenLre for Lhe PlsLory of Sclences and PumanlLles, lnsLlLuLe for
ConLemporary PlsLory, Academy of Sclences of Lhe Czech 8epubllc
139 Marlowe 1essmer Senlor LdlLor, !"# %&'()*+ &, AP=#(18#)7*+ >#:151)#
140 8oberL 1[lan resldenL, Poward Pughes Medlcal lnsLlLuLe
141 CerrlL van Meer uean of Lhe laculLy of Sclences, uLrechL unlverslLy
142 eLr vanysek LdlLor, %&'()*+ &, !"# A+#57(&5"#815*+ 4&51#7/ *): A34 A+#57(&5"#8107(/ K#77#(0
143 lnder verma LdlLor-ln-Chlef, .(&5##:1)20 &, !"# B*71&)*+ 65*:#8/ @, 451#)5#0 Q.B64R
144 Mlchael Way LdlLor-ln-Chlef, %&'()*+ &, 3#++ 451#)5#
143 Pelner Weber uean, CenLer for uenLlsLry and Cral Medlclne, Chalrman, ueparLmenL of
rosLhodonLlcs, unlverslLy of 1ueblngen, Cermany
146 Lrlc WesLhof ulrecLeur, lnsLlLuL de blologle moleculalre eL cellulalre du Cn8S, SLrasbourg, lrance
147 kaLhleen WeLs ubllsher, l1000rlme
148 lellx Wleland Managlng LdlLor, MA?4 K#77#(0
149 Llz Wllllams LxecuLlve LdlLor, !"# %&'()*+ &, 3#++ ?1&+&2/
130 MlLsuhlro ?anaglda LdlLor-ln-Chlef, -#)#0 7& 3#++0
131 Alpha ?ap Pead, ulvlslon of Molecular Cell 8lology, lnsLlLuLe for Molecular 8losclence, 1he
unlverslLy of Cueensland
132 Mary ?ess uepuLy LxecuLlve ulrecLor and ubllsher, LCS - 1he LlecLrochemlcal SocleLy
133 Marlno Zerlal Max lanck ulrecLor, Max lanck lnsLlLuLe of Molecular Cell 8lology and CeneLlcs,
uresden
134 ?a-plng Zhang vlce-resldenL, Chlnese Academy of Sclences
133 !lil ZlaLuska 8ecLor emerlLus, rofessor, Masaryk unlverslLy, 8rno, Czech 8epubllc
1 Academy of Sclences of Lhe Czech 8epubllc (AS C8)
2 AlLmeLrlc LL
3 Amerlcan AssoclaLlon for Lhe AdvancemenL of Sclence (AAAS)
4 Amerlcan Cll ChemlsLs' SocleLy
3 Amerlcan SocleLy for Cell 8lology
6 Amerlcan SocleLy of Agronomy
7 AssoclaLlon for sychologlcal Sclence
8 AusLrlan Sclence lund (lWl)
9 !"#$#%& ()*+
10 8rlLlsh SocleLy for Cell 8lology
11 ,!-./"0* 12"*+2*3 -45267"#+
12 ,*$$ 17852758* 6+4 95+27"#+ (a [ournal publlshed by !apanese SocleLy of Cell 8lology)
13 CenLro naclonal de Anallsls Cenomlco (CnAC)
14 Crop Sclence SocleLy of Amerlca
13 Czech MaLhemaLlcal SocleLy
16 ueparLmenL of Cell 8lology, unlverslLy of 1exas SouLhwesLern Medlcal CenLer
17 :*;*$#)<*+7
18 :"3*63* =#4*$3 > =*2?6+"3<3
19 LCS - 1he LlecLrochemlcal SocleLy
20 */"0*
21 LM8C
22 LuCheMS
23 Luropean AssoclaLlon of Sclence LdlLors
24 Luropean AssoclaLlon of Soclal AnLhropologlsLs
23 Luropean AsLronomlcal SocleLy (LAS)
26 Luropean ALherosclerosls SocleLy (LAu)
27 Luropean Councll of uocLoral CandldaLes and !unlor 8esearchers (Lu8CuCC)
28 Luropean CrysLallographlc AssoclaLlon
29 Luropean LducaLlon 8esearch AssoclaLlon (LL8A)
30 Luropean lederaLlon for Medlclnal ChemlsLry (LlMC)
31 Luropean Claucoma SocleLy
32 Luropean MaLhemaLlcal SocleLy
33 Luropean CpLlcal SocleLy
34 Luropean SocleLy for Soll ConservaLlon
33 Luropean SocleLy for Lhe PlsLory of Sclence
36 Luropean Soclologlcal AssoclaLlon
37 laculLy of 1000
38 9-!1 @#58+6$
39 9-!1 /*77*83
40 9-!1 ()*+ !"#
41 lederaLlon of Luropean 8lochemlcal SocleLles
42 londazlone 1eleLhon
43 Carvan lnsLlLuLe of Medlcal 8esearch
44 CeneLlcs SocleLy of Amerlca (CSA)
43 Cordon and 8eLLy Moore loundaLlon
46 Plgher LducaLlon lundlng Councll for Lngland (PLlCL)
!"#$ &' ()"*"+,- ."*+/)# 0()*,+"1,$"&+#2
47 Poward Pughes Medlcal lnsLlLuLe
48 lmpacLSLory
49 lnsLlLuLe for Molecular 8losclence, 8rlsbane AusLralla
30 lnsLlLuLe of MaLhemaLlcs, Academy of Sclences of Lhe Czech 8epubllc, rague
31 @#58+6$ #0 ,*$$ 12"*+2*
32 @#58+6$ #0 A*58#2?*<"378& (SocleLy !ournal of Lhe lnLernaLlonal SocleLy of neurochemlsLry)
33 LlngulsLlc SocleLy of Amerlca
34 =62*4#+"6+ @#58+6$ #0 ,?*<"378& 6+4 ,?*<"26$ -+%"+**8"+%
33 Medlcal 8esearch Councll LaboraLory of Molecular Cell 8lology
36 =#$*25$68 (+2#$#%&
37 =#$*25$68 !"#$#%& #0 7?* ,*$$
38 naclonal de Anallsls Cenomlco (CnAC), 8arcelona, Spaln
39 eer!
60 B8#2**4"+%3 #0 C?* A67"#+6$ D264*<& (0 12"*+2*3 EBAD1F
61 ubllc Llbrary of Sclence (LCS)
62 SocleLy of ChemlsLs and 1echnologlsLs of Macedonla
63 SocleLy of Lconomlc CeologlsLs
64 Soll Sclence SocleLy of Amerlca
63 Spanlsh CrysLallographlc AssoclaLlon (CL3C)
66 Swlss Academy of Medlcal Sclences
67 1he Amerlcan hyslologlcal SocleLy
68 C?* D+67#<"26$ G*2#84
69 1he AssoclaLlon of AusLrallan Medlcal 8esearch lnsLlLuLes
70 1he 8lonlcs lnsLlLuLe
71 1he Company of 8lologlsLs
72 1he Luropean SocleLy for PlsLory of Sclence
73 1he lnLernaLlonal SocleLy of AddlcLlon !ournal LdlLors
74 C?* @#58+6$ #0 ,*$$ !"#$#%&
73 C?* @#58+6$ #0 -H)*8"<*+76$ !"#$#%&
76 1he Macfarlane 8urneL lnsLlLuLe for Medlcal 8esearch and ubllc PealLh (8urneL lnsLlLuLe)
77 vlcLor Chang Cardlac 8esearch lnsLlLuLe
78 Wellcome 1rusL